Cargando…
Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review
BACKGROUND: Systematic screening for active tuberculosis (TB) is a strategy which requires the health system to seek out individuals, rather than waiting for individuals to self-present with symptoms (i.e., passive case finding). Our review aimed to summarize the current economic evidence and unders...
Autores principales: | Alsdurf, H., Empringham, B., Miller, C., Zwerling, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425319/ https://www.ncbi.nlm.nih.gov/pubmed/34496804 http://dx.doi.org/10.1186/s12879-021-06633-3 |
Ejemplares similares
-
Cost-Effectiveness Analysis of High-Risk Groups Tuberculosis Screening in Malaysia
por: Mohd Hassan, Nor Zam Azihan, et al.
Publicado: (2021) -
Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis
por: Mullie, Guillaume A., et al.
Publicado: (2017) -
How much does HIV self-testing cost in low and middle income countries? A systematic review of evidence from economic studies
por: Empringham, Brianna, et al.
Publicado: (2023) -
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
por: Lai, Wendy A., et al.
Publicado: (2022) -
Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
por: Gomez, G. B., et al.
Publicado: (2016)